Novel data point to a broader mechanism of action of oxidized ATP: the P2X7 receptor is not the only target
- 1 October 2003
- journal article
- editorial
- Published by Wiley in British Journal of Pharmacology
- Vol. 140 (3) , 441-443
- https://doi.org/10.1038/sj.bjp.0705469
Abstract
Oxidized ATP (oATP) is a Schiff-base-forming reagent that has been used for some years as an antagonist at the P2X7 receptor (P2X7R). Preincubation of mononuclear phagocytes with this inhibitor leads to attenuation of several proinflammatory responses triggered by extracellular ATP as well as a few non-nucleotide agonists. Novel data show that oATP reduces NFkappaB activation and IL-8 release in cells lacking P2X7R, thus suggesting that some anti-inflammatory effects of oATP may not be due to blockade of the P2X7R. This effect of oATP resembles the action of other natural or synthetic Schiff-base-forming reagents with immunomodulatory activity.Keywords
This publication has 15 references indexed in Scilit:
- Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor‐independent mechanismsBritish Journal of Pharmacology, 2003
- Deletion of the P2X7Nucleotide Receptor Reveals Its Regulatory Roles in Bone Formation and ResorptionMolecular Endocrinology, 2003
- Alerting and tuning the immune response by extracellular nucleotidesJournal of Leukocyte Biology, 2003
- Marked Enhancement of the Antigen-Specific Immune Response by Combining Plasmid DNA-Based Immunization with a Schiff Base-Forming DrugInfection and Immunity, 2002
- Discovery of immunopotentiatory drugs: current and future strategiesClinical and Experimental Immunology, 2002
- Differential Assembly of Rat Purinergic P2X7 Receptor in Immune Cells of the Brain and PeripheryPublished by Elsevier ,2001
- A unifying purinergic hypothesis for the initiation of painThe Lancet, 1996
- The Cytolytic P 2Z Receptor for Extracellular ATP Identified as a P 2X Receptor (P2X 7 )Science, 1996
- Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugsNature, 1995
- PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responsesEuropean Journal of Pharmacology, 1992